Ciprofloxacin

Product NDC
71335-2097
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ciprofloxacin
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA208921
Marketing category
ANDA
Substance
CIPROFLOXACIN HYDROCHLORIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
71335-2097-07 TABLET, COATED in 1 BOTTLE (71335-2097-0) 20240403NoHistorical
71335-2097-120 TABLET, COATED in 1 BOTTLE (71335-2097-1) 20220624NoHistorical
71335-2097-210 TABLET, COATED in 1 BOTTLE (71335-2097-2) 20220705NoHistorical
71335-2097-314 TABLET, COATED in 1 BOTTLE (71335-2097-3) 20220722NoHistorical
71335-2097-46 TABLET, COATED in 1 BOTTLE (71335-2097-4) 20221028NoHistorical
71335-2097-530 TABLET, COATED in 1 BOTTLE (71335-2097-5) 20240403NoHistorical
71335-2097-660 TABLET, COATED in 1 BOTTLE (71335-2097-6) 20240403NoHistorical
71335-2097-712 TABLET, COATED in 1 BOTTLE (71335-2097-7) 20240403NoHistorical
71335-2097-840 TABLET, COATED in 1 BOTTLE (71335-2097-8) 20240403NoHistorical
71335-2097-990 TABLET, COATED in 1 BOTTLE (71335-2097-9) 20240403NoHistorical

Related DailyMed Labels

Set IDTitleManufacturerEffective dateTypeVersion
5af16acc-51ce-41ed-b1c4-6b3fb38ef515These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN TABLETS, for oral use Initial U.S. Approval: 1987Bryant Ranch Prepack2024-04-03HUMAN PRESCRIPTION DRUG LABEL103